TBPH

Theravance Biopharma (TBPH)

About Theravance Biopharma (TBPH)

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Details

Daily high

$17.96

Daily low

$17.46

Price at open

$17.68

52 Week High

$20.33

52 Week Low

$7.90

Market cap

900.4M

Dividend yield

0.00%

Volume

507,228

Avg. volume

546,724

P/E ratio

31.59

Theravance Biopharma News